Large Study Finds No Survival Benefit Associated With Removal Of Ovaries
ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer
Study Links Obesity To Higher Risk of Ovarian Cancer
Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
Early HER2 Positive Patients At Higher Risk of Recurrence
Tykerb Plus Letrozole Delayed Metastatic Breast Cancer
Estrogen Can Benefit Women With Metastatic Breast Cancer
Alternating Mammography, MRI Tested For High-Risk Women
Degarelix Approved For Advanced Prostate Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?
